Search research articles
Contact Us
Filters
Showing results (41-50 of 101) with videos related to
Page
of 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 27, 2020
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?
Samuel L Aitken, Virginia M Pierce, Jason M Pogue, et al.
Diagnostic Microbiology and Infectious Disease
|
December 3, 2014
Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship
Samuel L Aitken, Vagish S Hemmige, Hoonmo L Koo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 18, 2023
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2022
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2025
Antimicrobial Stewardship and Beyond: The Many Essential Roles of Infectious Diseases Pharmacists
Wesley D Kufel, Conan MacDougall, Samuel L Aitken, et al.
Pharmacogenetics and Genomics
|
February 7, 2026
The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposure
Katherine Zhao, Vy Lam, Gregory Eschenauer, et al.
Open Forum Infectious Diseases
|
April 27, 2019
Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey
Dimitrios P Kontoyiannis, Emily C Shah, Sebastian Wurster, et al.
The American Journal of the Medical Sciences
|
January 22, 2015
Echinocandin use in hospitalized patients: a multi-institutional study
Kevin W Garey, Samuel L Aitken, Anthony Dima-Ala, et al.
The Annals of Pharmacotherapy
|
May 5, 2026
Crushed Posaconazole Delayed-Release Tablets Have Reduced Bioavailability and Interaction With Tacrolimus Relative to Other Administration Routes
Kathryn Flynn, Haley Hixson, Samuel L Aitken, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 101) with videos related to
Sort By:
Page
of 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 27, 2020
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2024
The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?
Samuel L Aitken, Virginia M Pierce, Jason M Pogue, et al.
Diagnostic Microbiology and Infectious Disease
|
December 3, 2014
Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship
Samuel L Aitken, Vagish S Hemmige, Hoonmo L Koo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 18, 2023
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2022
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2025
Antimicrobial Stewardship and Beyond: The Many Essential Roles of Infectious Diseases Pharmacists
Wesley D Kufel, Conan MacDougall, Samuel L Aitken, et al.
Pharmacogenetics and Genomics
|
February 7, 2026
The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposure
Katherine Zhao, Vy Lam, Gregory Eschenauer, et al.
Open Forum Infectious Diseases
|
April 27, 2019
Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey
Dimitrios P Kontoyiannis, Emily C Shah, Sebastian Wurster, et al.
The American Journal of the Medical Sciences
|
January 22, 2015
Echinocandin use in hospitalized patients: a multi-institutional study
Kevin W Garey, Samuel L Aitken, Anthony Dima-Ala, et al.
The Annals of Pharmacotherapy
|
May 5, 2026
Crushed Posaconazole Delayed-Release Tablets Have Reduced Bioavailability and Interaction With Tacrolimus Relative to Other Administration Routes
Kathryn Flynn, Haley Hixson, Samuel L Aitken, et al.
Page
of 11